| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Jun 24 | FATE Fate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.68 | 40,000 | 147.20 k | 40,000 |
| 30 May 24 | ATYR aTyr Pharma | Common Stock | Buy | Acquire P | Yes | No | 1.75 | 50,000 | 87.50 k | 56,000 |
| 22 May 24 | ATYR aTyr Pharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.86 | 24,000 | 44.64 k | 24,000 |
| 8 May 24 | TVTX Travere Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 6,500 | 0.00 | 49,000 |
| 8 May 24 | TVTX Travere Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 6.82 | 19,500 | 132.99 k | 19,500 |
